Search Weight Loss Topics:


Page 20«..10..19202122..30..»


Nov 28

Human Growth Hormone Market is Expected To See Opportunities Worth US$1600 mn by the End of 2026 – Kentucky Reports

Transparency Market Research points out that the competitive landscape in theglobal human growth hormone marketis fairly consolidated. Players continue to focus on developing products with minimal side effects. To expand business to newer markets several vendors are looking at mergers and acquisitions. Collaborations has become an important part of talent acquisitions for better drug development. For instance OPKO and Pfizer are collaborating to develop and sell human growth hormone hGH-CTP for treating adults and children. Some of the leading players operating in the global human growth hormone market are Merck KGaA, Eli Lilly and Company, Pfizer Inc., Novo Nordisk A/S, and Novartis AG.

According to the research report, the global human growth hormone market is expected to be worth US$ 5,261.5 mn by the end of 2026 in terms of revenue. During the forecast years of 2017 and 2026 the global market for human growth hormone is projected to surge at a CAGR of 6.2%. Out of the many routes of administration, the subcutaneous route of administration is projected to garner the highest revenue of US$1,600 mn by the end of 2026. It continuous to be the most preferred type of chronic growth therapy. From a geographic point of view, North America human growth hormone market is expected to remain in the leading position to strong presence of players.

Request a Sample of Human Growth Hormone Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16283

Rising Incidences of Chronic Conditions amongst Children and Adults Boosts Uptake of Human Growth Market

The growing application of growth hormones in treating many diseases and conditions has created a plethora of opportunities for the global human growth hormone market. The global market for human growth hormone is also being driven by the increasing awareness about the effectiveness of growth hormones in rectifying short statures. Children suffering from congenital conditions have significantly benefited from growth hormones. Meanwhile, adults with issues pertaining to pituitary gland have also led to a growing demand for human growth hormone therapies. Today, rising incidences of HIV/AIDS, growing research and development of long acting drugs, increasing cases of cancer, improving expenditure on healthcare, and commonly found growth hormone deficiencies have all augmented the global human growth hormone market.

The research report also points out that rising incidences of pituitary tumors, neuropsychiatric-cognitive, skeletal abnormalities, neuromuscular, cardiovascular, and metabolic abnormalities are expected to seek human growth hormone therapies as effective solutions. Majority of these ailments can be alleviated with the help of growth hormones. The report also states that the human growth hormone therapies are predominantly used for Tuner syndrome as these treatments are designed to treat poor sexual as well as physical developments. Thus, the increasing scope of application of human growth hormones is projected to take the global market to newer heights.

Request for a Discount on Human Growth Hormone Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16283

Illicit Use of Drugs Likely to Hamper Global Human Growth Hormone Market

On the flip side, the global human growth hormone market is challenged by a few elements. The high cost of these drugs and therapies is the key reason holding the market back from achieving bigger market size. Additionally, illegal usage of growth hormones amongst sportsmen has become the biggest challenge for the global human growth hormone market. The report emphatically states that the adverse side-effects of these drugs is also been a major concern for the overall market.

Go here to read the rest:
Human Growth Hormone Market is Expected To See Opportunities Worth US$1600 mn by the End of 2026 - Kentucky Reports


Nov 24

Jets Bell rips NFL for random 5th HGH test – San Antonio Express-News

FLORHAM PARK, N.J. (AP) LeVeon Bell is throwing a flag on the NFLs drug testing policy.

The New York Jets running back says Wednesday is upset he has been randomly selected five times this season by the league to take tests for performance-enhancing drugs.

I done had 5 random HGH blood test in 10 weeks, Bell tweeted. (at)NFL Im not doing another after today, whatever yall lookin for it obviously aint there.

Bell doubled down on his Twitter comment after practice, saying its getting weird and reiterating that he will not take additional tests this season although he stopped short of saying the league is targeting him with the testing.

Im not going to say all that, Bell said in the locker room. Im just saying Im not doing it no more. Theyre not getting no more of my blood. They can use the blood theyve got right now.

The random drug testing is part of a collectively bargained policy between the NFL and NFL Players Association. An independent administrator determines via a computer program which players are tested each week.

Is it random, though? Bell said. Why do I feel like every time theyre here doing the HGH testing, I get picked?

Per NFL rules, players with no previous violations of the policy on performance enhancers wont be tested more than six times in a calendar year.

Weve been playing the season for 10 weeks and Ive been tested five times for HGH, Bell said. On average, its like once every two weeks, right? Every two weeks, you all been testing me and havent found nothing, so what are yall looking for?

I just dont understand.

If Bell does get randomly selected for a sixth test over the last five weeks of the season and he refuses to take it, the league could consider it a failed test and choose to discipline him with suspension a possibility.

If we have to cross that bridge, well cross that bridge when we get there, Bell said.

Bell wrote on Twitter hell refuse to have the league stick me with dirty needles. He clarified that comment saying he simply dislikes needles, in general, and prefers urine testing.

You want me to pee in a cup, I can do that all day, he said. Just, I ain't trying to do it with needles. Needles, you can get that away from me.

Bell was suspended by the NFL for two games in 2014 while he was with Pittsburgh after he was charged with marijuana possession and DUI, a violation of the leagues substance abuse policy. He was also suspended four games in 2016 for missing a test.

He signed with the Jets last March after sitting out last season in a contract dispute with Pittsburgh. Bell made headlines this summer when he was forced to miss portions of training camp practices on consecutive days to take league-mandated tests.

Bell is off to the worst start of his career, averaging just 3.2 yards per carry. He has also yet to rush for more than 100 yards in a game this season. Bell is second on the team in receptions with 46 for 309 yards and one TD.

NOTES: RT Chuma Edoga (ankle), S Matthias Farley (quadriceps), LB C.J. Mosley (groin), CB Darryl Roberts (calf), LB Paul Worrilow (quadriceps) all did not practice. ... DE Henry Anderson (shoulder), LT Kelvin Beachum (ankle), LB Brandon Copeland (hip, thumb), LB Neville Hewitt (neck, knee), G Alex Lewis (elbow, shoulder), NT Steve McLendon (neck) and WR Demaryius Thomas (hamstring) were limited.

___

More AP NFL: https://apnews.com/NFL and https://twitter.com/AP_NFL

View post:
Jets Bell rips NFL for random 5th HGH test - San Antonio Express-News


Nov 24

Giants vs. Bears LIVE SCORE UPDATES and STATS (11/24/19) NFL Week 12 – NJ.com

The New York Giants, led by rookie quarterback Daniel Jones, meet the Chicago Bears, led by quarterback Mitchell Trubisky, in an NFC Week 12 NFL football game on Sunday, November 24, 2019 (11/24/19) at Soldier Field in Chicago, Illinois.

Check the scoreboard below for up-to-the-minute scoring and stats.

Giants running back Saquon Barkley wants to start having fun again.

Since returning from a high ankle sprain to his right ankle more than a month ago, Barkley has carried 64 times for 165 yards, an average of 2.57 yards. Against the Jets, he gained 1 yard on 13 carries, a career low.

Im just going to go out there and ball and have fun and go out there with my brothers, and whatever happens, happens, he said Thursday. Im not going to be worried about if hes hitting it too much or if hes not doing this or doing that. The reason I got drafted here is the reason Im one of the best running backs in the league, and Im just going to go out there and play and do what I do.

Heres what you need to know:

Who: New York Giants vs. Chicago Bears

What: NFL, Week 12

Where: Soldier Field, Chicago, Ill.

When: Sunday, Nov. 24, 2019

Time: 1 p.m. EDT

TV: Fox

Announcers: Thom Brenneman (play-by-play), Chris Spielman (analyst), Shannon Spake (sideline reporter)

Radio: WFAN

Announcers: Bob Papa (Play by play), Carl Banks (Color commentator), Howard Cross (sideline reporter)

Channel finder: Verizon Fios, AT&T U-verse, Comcast Xfinity, Spectrum/Charter,Optimum/Altice, DIRECTV, Dish, Hulu, fuboTV, Sling.

Live stream: Hulu, Sling

Betting line: Bears -6.5 | Get betting tips and analysis at nj.com/betting

GIANTS NOTES

QB DANIEL JONES (rookie) had 308 pass yards & 4 TDs vs. 0 INTs for 121.7 rating in Week 10. Is 1st rookie QB in NFL history with 2 games of 300+ pass yards & 4+ TDs. Has 13 TDs (11 pass, 2 rush) vs. 3 INTs for 101.9 rating in 4 career road starts.

RB SAQUON BARKLEY has 289 scrmimage yards (144.5 per game) & rec. TD in 2 career games vs. NFC North. Since 2018, ranks 3rd in NFL with 2,688 scrimmage yards. Has 16 games with 100+ scrimmage yards since 2018, tied-2nd most in NFL.

WR DARIUS SLAYTON (rookie) had career-highs in receptions (10) & rec. yards (121) & had 2 rec. TDs in Week 10. Aims for his 3rd in row on road with 2+ TD catches. Is only rookie in 2019 with 2 games of 2+ rec. TDs. WR GOLDEN TATE had 95 rec. yards & 2 TD catches in Week 10, his 7th career game with 2+ rec. TDs. Has 7+ receptions & 80+ rec. yards in 2 of his past 3 on road vs. NFC North. TE EVAN ENGRAM has rec. TD in 2 of his 3 career games vs. NFC North.

LB MARKUS GOLDEN had sack in Week 10. Has 4 sacks & FR-TD in his past 4 on road. LB ALEC OGLETREE is 1 of 3 LBs (JAMIE COLLINS & LAVONTE DAVID) with 10+ FFs (12) & 10+ INTs (11) since 2013. CB JANORIS JENKINS had 3 PD in last meeting. Aims for his 6th in row vs. Chi. with PD. Since 2012, ties for NFL lead with 102 PD. DT DALVIN TOMLINSON had career-high 9 tackles last week. Aims for his 3rd in row on road with sack. S ANTOINE BETHEA ranks 2nd among DBs in tackles (360) since 2016.

BEARS NOTES

QB MITCHELL TRUBISKY has 2+ TD passes in 2 of his past 3 starts at home. QB CHASE DANIEL had 2 TDs vs. 2 INTs for 89.7 rating in only start in 2019 (Week 5 vs. Oak.). Passed for career-hgh 285 yards & TD in last meeting.

RB TARIK COHEN had 74 scrimmage yards (39 rush, 35 rec.) & TD catch last week, his 9th career rec. TD. Aims for his 3rd in row with TD catch. Has 167 receptions since 2017, 4th-most among RBs. RB DAVID MONTGOMERY ranks 2nd among rookies in rush yards (497) & rush TDs (5) & ranks 3rd in scrimmage yards (649).

WR ALLEN ROBINSON aims for his 6th in row at home with 5+ receptions & 60+ rec. yards. Had 5 catches for 79 yards in last meeting. WR TAYLOR GABRIEL tied his career-high with 7 receptions & led team with 57 rec. yards last week. WR ANTHONY MILLER had career-high 6 receptions & had 54 rec. yards in Week 11.

LB KHALIL MACK had sack in last meeting. Aims for his 3rd in row vs. NYG with sack. Has 11 sacks & 6 FFs in 12 career home games with Chi. LB ROQUAN SMITH had 11 tackles & 2nd career INT last week. Aims for his 4th in row with 10+ tackles. LB LEONARD FLOYD had sack in last meeting. S EDDIE JACKSON had career-high 2 TFL & 4th career FF last week. S HA HA CLINTON-DIX had 4th career FR in Week 11. CB KYLE FULLER had 3 PD & INT in last meeting. Has 51 PD since 2017, most in NFL. -- NFL Communications

Follow this link:
Giants vs. Bears LIVE SCORE UPDATES and STATS (11/24/19) NFL Week 12 - NJ.com


Nov 18

Infrared Search & Track (IRST) Systems Market Technology Advancements and Outlook 20192025 Lockheed Martin, Thales Group, Saab – The Connect…

This report provides a comprehensive 360-degree perspective on the demand for Infrared Search & Track (IRST) Systems Market, putting out perspectives that can help investors recognize both opportunities and challenges. It monitors the global market for Infrared Search & Track (IRST) Systems through key markets, offering in-depth analysis and detailed statistical insights. The study also includes incisive competitive analysis of the landscape and provides Infrared Search & Track (IRST) Systems market players with key recommendations on winning imperatives and successful strategies.

In this study, the growth aspects that will drive the information of the forecast Infrared Search & Track (IRST) Systems are elaborated. This report presents comprehensive information on regional statistics on Infrared Search & Track (IRST) Systems in the industry, development trends, SWOT analysis.

For In-depth Information Get Free Sample Copy of this Report@ https://www.researchkraft.com/request-sample/1004072

Lockheed Martin, Thales Group, Saab, Boeing, Safran, Rheinmetall, Aselsan, Leonardo, Northrop Grumman, HGH Systemes Infrarouges, Hughes Aircraft Company

Click here to get discount@ https://www.researchkraft.com/check-discount/1004072

North America (U.S., Canada, Mexico)Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)Asia-Pacific (China, India, Japan, Southeast Asia, etc.)South America (Brazil, Argentina, etc.)Middle East & Africa (South Africa, Saudi Arabia, etc.)

The report provides detailed and up-to-date statistical analysis on the global Infrared Search & Track (IRST) Systems market. The report presents a variety of factors such as import-export details, sales, regional presence, manufacturer analysis, latest trends, and competitive structure. Crucial information is defined, such as the chain structure of Infrared Search & Track (IRST) Systems, upstream and downstream customers, market volume and sales revenue.

Key Highlights of This Report:

For More Information On This Report, Please Visit @ https://www.researchkraft.com/send-an-enquiry/1004072

More here:
Infrared Search & Track (IRST) Systems Market Technology Advancements and Outlook 20192025 Lockheed Martin, Thales Group, Saab - The Connect...


Nov 13

Hartford Financial Services Group, Inc. (The) ($HGH): The Good, The Bad, The Ugly (2019-11-08) – WCX19

REPORTING FOR 2019-11-08 | WCX19.ORG: We have done an in-depth analysis of how HGH has been trading over the last 2 weeks and the past day especially. On its latest session, Hartford Financial Services Group, Inc. (The) ($HGH) opened at 28.17, reaching a high of 28.2641 and a low of 28.05 before closing at a price of 28.09. There was a total volume of 42348.

VOLUME INDICATORS FOR HARTFORD FINANCIAL SERVICES GROUP, INC. (THE) ($HGH): We saw an accumulation-distribution index of 222.19293, an on-balance volume of 28.26, chaikin money flow of 3.55048 and a force index of 0.013. There was an ease of movement rating of -0.00015, a volume-price trend of -0.62916 and a negative volume index of 1000.0.

VOLATILITY INDICATORS FOR HARTFORD FINANCIAL SERVICES GROUP, INC. (THE) ($HGH): We noted an average true range of 0.10889, bolinger bands of 28.26056, an upper bollinger band of 27.94944, lower bollinger band of 28.05, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 28.16137, high band keltner channel of 28.06727, low band keltner channel of 28.25547, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 28.05, a donchian channel low band of 28.05, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.

TREND INDICATORS FOR HARTFORD FINANCIAL SERVICES GROUP, INC. (THE) ($HGH): We calculated a Moving Average Convergence Divergence (MACD) of 0.00247, a MACD signal of 0.00137, a MACD difference of 0.0011, a fast Exponential Moving Average (EMA) indicator of 28.05, a slow Exponential Moving Average (EMA) indicator of 28.05, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.41054, a trix of -2.11227, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 0.64059, a KST Oscillator (KST) of -22.3276 and a KST Oscillator (KST Signal) of -22.3276 (leaving a KST difference of 0.9585). We also found an Ichimoku rating of 28.21705, an Ichimoku B rating of 28.21705, a Ichimoku visual trend A of 28.82601, an Ichimoku visual trend B of 28.78012, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.

MOMENTUM INDICATORS FOR HARTFORD FINANCIAL SERVICES GROUP, INC. (THE) ($HGH): We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 50.22645, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -50.20024, a stochastic oscillator of 227.52391, a stochastic oscillator signal of 227.52391, a Williams %R rating of 127.52391 and an awesome oscillator of 0.03516.

RETURNS FOR HARTFORD FINANCIAL SERVICES GROUP, INC. (THE) ($HGH): There was a daily return of -2.23276, a daily log return of 0.39139 and a cumulative return of 0.39216.

What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and thats OK (though we do advise learning these things). The bottom line is that AS OF 2019-11-08 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Hartford Financial Services Group, Inc. (The) ($HGH)

DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Hartford Financial Services Group, Inc. (The) ($HGH) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.

Read the original:
Hartford Financial Services Group, Inc. (The) ($HGH): The Good, The Bad, The Ugly (2019-11-08) - WCX19


Nov 13

Dime Drop: Does the NBA have a PED problem? – GIVEMESPORT

Whilst the on-court start to the NBA season has been the most exciting in recent memory, off the court, the league finds itself facing difficulties and a potential image crisis.

On Tuesday, the Atlanta Hawks promising young forward, John Collins, was suspended for 25 games for violating the NBAs Anti-Drug Program. Collins, in his third season, has seen his stock rise considerably as his partnership with Trae Young blossomed into one of the most promising tandems in the league. Now the future of that partnership and the surprisingly hopeful season which lay ahead for the Hawks is uncertain.

The 22-year-old tested positive for Growth Hormone Releasing Peptide-2 (GHRP-2), a banned PED which (as the name suggests) stimulates the release of Human Growth Hormone (HGH) as well as (not as the name suggests) increasing appetite. That, in itself, is a story. But there is more going on here, as Collins became the third player to be suspended from play this season for violating the Anti-Drug Program testing positive for either PEDs or flushing agents.

In August, Wilson Chandler of the Brooklyn Nets tested positive for Ipamorelin

In October, DeAndre Ayton of the Phoenix Suns was found to have a diuretic in his system.

Three players. Three 25 game bans.

As part of the 2011 Collective Bargaining Agreement, the NBPA and league agreed to implement blood testing for HGH. In April 2015, it was announced that testing would be implemented for the 2015-16 season. Since that time, ten players have been suspended by the league, with five of those testing positive for steroids, performance-enhancing drugs or masking agents. Those five; Joakim Noah in March 2017, Jodie Meeks in April 2018 and now, in quick succession, Chandler, Ayton and Collins.

Whilst the dates of the positive tests have not been disclosed, three announcements in short succession have the air of a crackdown. Proportionally, three from the pool of 450 players is just 0.0067%, which gives hope that this is just an unfortunate coincidence.

The leagues anti-drug program can subject players to four urine tests and two blood tests in season, alongside two urine tests and one blood test each offseason. Tests are scheduled and undertaken independently of the NBA and NBPA, with players having no prior warning they are to be tested. Crucially, beyond this, additional tests can be undertaken with reasonable cause, meaning there is always the potential for a player to be caught.

Ultimately, we need to hope that this is just the league sending a warning shot to players (that the risks and repercussions, both personally and professionally, of using PEDs significantly outweigh any potential rewards), rather than an indicator of a systemic issue amongst players. Perhaps the timing of the bans and announcements is strategic, something the league hopes will fade in the public memory as the season progresses and fans continue to be consumed by the on-court action.

Speaking of...

Friday 8 November, 3:30 am (Saturday morning) - Miami Heat @ Los Angeles Lakers

The surprising Miami Heat (6-2) head to the Staples Center to take on a surging Lakers (6-1) team. The game presents, perhaps, one of the two toughest match-ups for the Heat. Itll be interesting to see how Bam Adebayos energy and athleticism matchs up with current Western Conference Player of the Week, Anthony Davis - especially in the second game of a tough back-to-back, having beaten the Suns 124 - 108 last night.

Saturday 9 November, 10 pm - Boston Celtics @ San Antonio Spurs

Boston (6-1) ride into San Antonio atop the Eastern Conference and tied with the Lakers for the best record in the league. The Spurs (5-3) have a reputation as one of the toughest teams to beat on their home floor and should prove a real test for the re-energised Celtics. This is a game with an array of talent on display, with established stars (Kemba Walker, DeMar DeRozan and LaMarcus Aldridge) and ascending talent (Jayson Tatum, Jaylen Brown, Dejounte Murray, Derrick White and Bryn Forbes) in abundance.

Sunday 10 November, 8:30 pm - Denver Nuggets @ Minnesota Timberwolves

The Nuggets (5-2) visit the Timberwolves (4-3), in a match-up that sees two of the league's best young bigs, in Nikola Jokic and Karl-Anthony Towns, face off. Denver appears to be finding their feet, having thumped the white-hot Heat by 20 on Tuesday and the Timberwolves will be looking to stop a potential slide, having given up over 130 points in each of their last two games (at time of writing), including a shock loss to Memphis.

You can hear more from Mike weekly on the Double Clutch Podcast, the UKs leading NBA podcast.

View original post here:
Dime Drop: Does the NBA have a PED problem? - GIVEMESPORT


Nov 13

Aerami Therapeutics to Present Clinical Data on Dance 501 Inhaled Human Insulin at the 19th Diabetes Technology Meeting – Yahoo Finance

DURHAM, N.C., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Aerami Therapeutics, a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, today announced that it will present two posters on its Dance 501 inhaled human insulin product candidate for type 1 and type 2 diabetes, at the 19th Diabetes Technology Meeting taking place on November 14-16, 2019 in North Bethesda, Maryland.

The poster presentations will describe findings from two clinical studies (SAMBA-03 and SAMBA-04) demonstrating the linear dose-response to Dance 501 versus insulin Lispro in patients with type 1 and type 2 diabetes, respectively. The inhaled human insulin was delivered through the lungs via Aeramis smart inhaler which generates a soft mist that allows for a drug deposition 2-4 times higher than conventional inhalers.1

We are pleased to present findings from our SAMBA studies on the dose response to Dance 501 in comparison to an injectable alternative because this further validates our smart inhaler can deliver optimal and precise therapeutic doses through the lungs, said Melissa Rhodes, chief development officer, Aerami Therapeutics. A number of chronic conditions could benefit from the frequent pulsatile administration afforded by an inhaled delivery option, so we are exploring use of the smart inhaler technology beyond diabetes, where patients could achieve better treatment efficacy.

Eric Zijlstra, Ph.D., lead study author and presenter commented, Treatment via a gentle inhalation could be a welcome alternative to routine injections allowing for improved drug absorption and efficacy while also providing a better patient experience. Moreover, treatment via inhalation could potentially lower the barriers to starting insulin treatment, thereby leading to better blood sugar control at an earlier time and fewer complications ahead.

Poster Presentation Details:

Poster Presentation #1: Dance 501 Inhaled Human Insulin: Linear Dose Response in Patients with Type 1 DiabetesPoster Number:54Presenter:Eric Zijlstra, PhDSession Date & Time:November 14, 2019, 4:30 - 6:30 pm ET

Poster Presentation #2: Faster Absorption and Greater Early Insulin Action of Dance 501 Inhaled Human Insulin vs. s.c. Insulin Lispro in Patients with Type 2 DiabetesPoster Number:55Presenter:Eric Zijlstra, PhDSession Date & Time:November 14, 2019, 4:30 - 6:30 pm ET

Additional details can be found on theconference website.

About Aerami Therapeutics

Aerami Therapeutics is a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies. Our gentle mist inhaler is designed with smart technology to optimize the precise delivery of biologic therapies through the lungs. We are building a diverse pipeline of inhaled biologic products with initial focus on rare and severe diseases in the endocrinology, respiratory and cardiovascular space, where our platform and expertise present a unique opportunity to achieve better treatment efficiency. We have initiated development programs in glucagon-like peptide-1 (GLP-1), parathyroid hormone (PTH) and human growth hormone (HGH).

For more information, visit: http://www.aerami.com

Investor Contact:Jeremy FefferLifeSci Advisors, LLC(212) 915-2568jeremy@lifesciadvisors.com

Media Contact:Gloria GasaaturaLifeSci Public Relationsggasaatura@lifescipublicrelations.com

1 Fink et al. 2017 Pharm Res

Originally posted here:
Aerami Therapeutics to Present Clinical Data on Dance 501 Inhaled Human Insulin at the 19th Diabetes Technology Meeting - Yahoo Finance


Oct 21

How to Convert HGH IU to Mg | Healthfully

Somatotropin, also known as human growth hormone or simply HGH, is a protein-based hormone that regulates growth within the human body. The hormone is typically used as a medical treatment for endocrine disorders that result in stunted growth in adolescents. Others have also used human growth hormone to enhance athletic performance and as an anti-aging drug. HGH is measured in International Units. When administering HGH, it may be necessary to convert from IU to milligrams. A simple arithmetic calculation provides the appropriate conversion.

Determine the dosage of HGH in IU.

Multiply the number of IU by 0.333, which is the number of mg in a single IU of HGH. The resulting product is the equivalent dosage in mg.

Convert a quantity of HGH in mg back to IU by multiplying the number of mg by 3.

This information is intended for educational purposes only. It is not provided to diagnose, treat, cure or prevent any illness.

See the rest here:
How to Convert HGH IU to Mg | Healthfully


Oct 20

HGH Sermorelin Acetate Therapy | HGH Therapy at Tampa …

While we were young our brains naturally stimulated the pituitary glands to produce ample amounts of Natural Releasing Hormones (GHRH), which promote and sustain health and vitality. As we age, less and less GHRH is produced by our brain causing the pituitary gland production of GHRH to decline, leading to a lower level of vitality, vigor and eventually health. At Tampa Rejuvenation, we are committed to people living life fully, with optimal health, energy, and stamina.

Sermorelin Acetate is a safe, natural and preferable method to stimulate the human body to increase production of GHRH. Sermorelin Acetate is compounded by pharmacies and requires a physicians prescription (it is not a genetically engineered Natural Releasing Hormone ).

Tampa Rejuvenations on-staff physicians are experts in hormone therapy and closely monitor our patients well-being while taking Sermorelin Acetate. Hormone therapy programs at Tampa Rejuvenation are comprehensive in nature and include: administrative services, initial physician consultations, medical laboratory testing, physicians physical examination, physicians medical assessment and evaluation of the patient, prescribed treatment plan, monthly doctor visits (if required or requested by the patient), recommended diet plans and physical fitness assessments and recommendations.

More:
HGH Sermorelin Acetate Therapy | HGH Therapy at Tampa ...


Oct 20

HGH and Testosterone Therapy Treatment Clinics in Tampa …

Human Growth Hormone and Testosterone Therapy in TampaHGH Testosterone Treatment Centers & Doctors in Tampa FLTestosterone Therapy in Tampa

Men's HGH and Testosterone levels decline as they age and it could specifically be Low Testosterone that is causing excessive weight gain, loss of sex drive, softer than normal erections, flabby muscles, unexplained mood swings, irritability, extreme fatigue, inability to sleep and depression. If your testosterone is low enough you may already have symptoms of erectile dysfunction or Andropause (Low T - the male menopause).

Both HGH and Testosterone decline with age. As men age testosterone levels naturally drop causing adverse health issues. It is a gradual, slow process and so you may have not noticed less sexual arousal, softer erections or less morning erections, shorter night's rest, moodiness and increasing bursts of anger, or the inability for your muscles to recover after working out.Most middle-aged men do notice, however, the rapid increase in weight and fat around the mid-section, flabby muscles, extreme fatigue, erectile dysfunction and feelings of depression that may be caused by hormonal imbalance or deficiency.

Human Growth Hormone Treatment using Somatropin HGH, is a safe and effective hormone treatment method for growth hormone deficiency, also known as AGHD. HGH Therapy is bio-identical or natural hormone optimization used by Endocrinologists and Anti-Aging Doctors who measure your level of hormone deficiency, and prescribe Somatropin which is a subcutaneous daily injection of Human Growth Hormone. Injectable HGH is the best form of HGH Therapy. For those patients who do not qualify for HGH Injections Therapy, Sermorelin Therapy using GHRH Peptide Injections is available. Read more about Sermorelin Injections online.

In addition to Injectable HGH or Somatropin for hormone replacement, other HRT programs include Testosterone Injections and Creams, Bio-Identical HRT, Low T Therapy, Sermorelin Injections, Sexual Health and Wellness, ED Therapy, Menopause Therapy, Stress & Weight Loss Management, IV Infusion Vitamin Therapies, Chelation and Testosterone Treatments, providedin Tampa by Board Certified Licensed Age Management Physicians who are Cenegenics, Mayo Clinic and Cleveland Clinic trained in Anti-Aging and Regenerative Medicine with a focus on "Healthy Aging".

Our Hormone Replacement Physicians provide hormone optimization, life extension, nutritional and anti-aging therapies to men and women residing in the USA.

HGH Brands for sale in the USA include Pfizer Genotropin, MiniQuick Pen, Sandoz Omnitrope, Novo Nordisk Norditropin, FlexPro Pen, NordiFlex Pen, and Eli Lilly Humatrope. Somatropin, the genuine injectable growth hormone comes in a vial HGH kit, or cartridge for use with an HGH pen device.

In addition to Hormone Treatment Programs using Injectable HGH for bio-identical hormone replacement, other HRT and TRT Programs include Combination HGH and Testosterone Treatment Plans using Testosterone Injections including Depo-Testosterone Steroid Hormone Shots, Delatestryl and Aveed, Topical Androgen Creams and Androgen Gels such as AndroGel, Fortesta, Axiron and Testim, Low T Treatment Programs with HCG and AI's Aromatase Inhibitiors (Arimidex), HCG Injections with Testosterone and Somatropin; Sermorelin Acetate Peptide Injections, GHRP-6 and GHRP-2 Hexapeptide Therapy.

Sexual Health and Wellness Programs for Men & Women, ED Treatment Programs using vasodilators and prostaglandin penile injections such as BiMix, Trimix Injections, Caverject, Edex and LI Shockwave Therapy for ED (male impotence ultrasound treatment), Menopause Treatment Programs for women using estrogen replacement, progesterone, oxytocin, and Female Sexual Health Programs including testosterone for women to boost libido and sexual arousal; Stress, Obesity & Medical Weight Loss Programs, Vitamin IV Infusion Therapies; Bio-Identical Hormone Programs are formulated by Endocrinologists, Urologists and Anti-Aging Medicine Doctors providing natural hormone optimization, Healthy Aging Programs, Life Extension and Longevity Programs, nutrition, fitness and anti-aging therapies to men and women residing in Tampa.

Men or women experiencing low energy, loss of sex drive or sexual dysfunction, rapid or excessive weight gain, Low T levels, loss of muscle mass due to low testosterone, extreme fatigue, inability to sleep, hot flashes, joint pain, slow recovery from workouts, lack of enthusiasm for life, irritability, mood swings or depression.

If you are looking to restore your energy levels and get back your enthusiasm for living, boost your sex drive, increase lean muscle mass, lose excess body fat and weight, trim your waist, reduce stress, sleep better, improve your vision and memory, reduce wrinkles, thicken your hair, look younger and feel younger - fill out the Quick Info Form for a Free HRT Doctor's Consultation.

At Tampa Optimal Hormone Therapy Center, we have served over 20,000 hormone patients and can offer you the absolute best service and pricing on HRT Therapy including Testosterone Injections and HGH Injections.

Contact us to find the various Hormone Lab Testing facilities to qualify for Anti Aging, Testosterone, HGH and HCG treatments if you live throughout the City of Tampa or Hillsborough County, FL

At Tampa Optimal Hormone Therapy Centers, we specialize in testosterone and HGH replacement therapy. You will be carefully listened to, all your questions answered, and closely monitored for any signs and symptoms or side effects. Your testosterone and HGH (IGF-1) levels and other necessary hormone blood levels will be thoroughly measured. Low Testosterone and Human Growth Hormone Deficiency are legitimate medical health conditions whose diagnosis affects a lot of men and women nationwide. The HRT physicians at Optimal Hormone Therapy Centers fully understand that not all family doctors or general practitioners are trained in bio-identical hormone therapy or comfortable treating individuals with low testosterone or and HGH deficiency.At our Testosterone and HGH clinics our experienced doctors recognize that optimal hormone levels are the goal and key to vitality and healthy aging.

testosterone therapy, replacement therapy, testosterone replacement, low testosterone, testosterone treatment, testosterone is, testosterone hormones, steroids, hormone therapy, bio identical, anti aging, about low t, low t, testosterone injections, therapy testosterone, testosterone treatment therapy, does testosterone therapy work, testosterone therapy near me, therapy testosterone for men, testosterone levels, low testosterone, low t levels, testosterone treatment growth hormone, sex drive, increase sex drive, increase libido, hgh and testosterone, hgh testosterone hormone replacement, male hormone replacement, andropause treatment, Doctors That Treat Low Testosterone,Doctors Specializing in Low Testosterone,What Doctor Treats Testosterone,Doctors Who Treat Low Testosterone, Tampa ED Therapy, Erectile Dysfunction Treatment, ED Clinics, Tampa Urologists,What Doctor Treats Low-T,Doctors for Testosterone Treatment,Low-T Doctors, low testosterone clinics, testosterone specialist doctor in Tampa,Testosterone Specialists,Testosterone Doctor, injections for low testosterone in men, Testosterone Specialist Doctor in Tampa, Hillsborough County Testosterone Therapy, human growth hormone therapy, hgh therapy, hgh injections, hgh therapy near me, local hgh clinics, real hgh

Common Tampa Testosterone Searches: Tampa Hormone Therapy, Andropause Treatment FL, Men's Clinic in the Tampa Bay area, Tampa Male Anti-Aging, Testosterone Replacement Therapy Tampa FL, Clearwater Testosterone Center, HGH Replacement Therapy St Petersburg, Palm Harbor Low T, Largo Low T, Human Growth Hormone Plant City, Pinellas Park FL, Human Growth Hormone Replacement Therapy, Citrus Park FL Testosterone Clinics; Apollo Beach Testosterone Replacement Therapy, Low Testosterone Therapy Wesley Chapel, Testosterone Replacement Therapy Tampa, Dunedin Testosterone Replacement Therapy; TRT Town 'N' Country Replacement Therapy, Growth Hormones Therapy; HGH Riverview, North Tampa Testosterone Replacement Therapy, New Port Richey FL Testosterone Replacement Therapy. HGH Replacement Therapy in Tampa.

Low Testosterone due to Andropause is a treatable and reversible male health condition. You needn't let Low T impact your self-esteem, your work life or your romantic relationships. You don't need to suffer, Male Hormone Therapy can help. If you are among the millions of men experiencing symptoms of low testosterone, get tested and treated today.

The physicians at Optimal Hormone Therapy are Cenegenics and Mayo-Clinic trained. Our doctors are nationally recognized experts in the field of hormone replacement therapy. If you think you may be suffering from low testosterone, schedule an appointment to have a complete and thorough analysis of your health. Once completed we will decide together with you which type of treatment is right for you.

Rejuvenate yourself and your health. Testosterone Replacement Therapy can restore your sex drive and desire, lose weight and increase your energy, mental alertness, strength and stamina.

Call Optimal Hormone Therapy at (888) 663-1777 to find out if you are a candidate for testosterone replacement therapy and other hormone enhancing treatments.

Human Growth Hormone (Somatropin Injections).

HGH Growth Hormone Replacement Therapy.

Anti-Aging Hormone Replacement Therapy.

TRT - Testosterone Replacement Therapy.

Testosterone for Sale - Buy Testosterone Online.

HGH for Sale - Buy HGH Injections Online.

HGH Pens for Sale - Buy Somatropin Pens Online.

Go here to see the original:
HGH and Testosterone Therapy Treatment Clinics in Tampa ...



Page 20«..10..19202122..30..»